These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 11877422)

  • 1. Amyloid-like fibril formation in an all beta-barrel protein involves the formation of partially structured intermediate(s).
    Srisailam S; Wang HM; Kumar TK; Rajalingam D; Sivaraja V; Sheu HS; Chang YC; Yu C
    J Biol Chem; 2002 May; 277(21):19027-36. PubMed ID: 11877422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amyloid-like fibril formation in an all beta-barrel protein. Partially structured intermediate state(s) is a precursor for fibril formation.
    Srisailam S; Kumar TK; Rajalingam D; Kathir KM; Sheu HS; Jan FJ; Chao PC; Yu C
    J Biol Chem; 2003 May; 278(20):17701-9. PubMed ID: 12584201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structurally homologous all beta-barrel proteins adopt different mechanisms of folding.
    Srimathi T; Kumar TK; Kathir KM; Chi YH; Srisailam S; Lin WY; Chiu IM; Yu C
    Biophys J; 2003 Jul; 85(1):459-72. PubMed ID: 12829501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amyloid fibril formation by a partially structured intermediate state of alpha-chymotrypsin.
    Pallarès I; Vendrell J; Avilés FX; Ventura S
    J Mol Biol; 2004 Sep; 342(1):321-31. PubMed ID: 15313627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time-dependent changes in the denatured state(s) influence the folding mechanism of an all beta-sheet protein.
    Kathir KM; Kumar TK; Rajalingam D; Yu C
    J Biol Chem; 2005 Aug; 280(33):29682-8. PubMed ID: 15941715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Partially unfolded states of beta(2)-microglobulin and amyloid formation in vitro.
    McParland VJ; Kad NM; Kalverda AP; Brown A; Kirwin-Jones P; Hunter MG; Sunde M; Radford SE
    Biochemistry; 2000 Aug; 39(30):8735-46. PubMed ID: 10913285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversible amyloid formation by the p53 tetramerization domain and a cancer-associated mutant.
    Lee AS; Galea C; DiGiammarino EL; Jun B; Murti G; Ribeiro RC; Zambetti G; Schultz CP; Kriwacki RW
    J Mol Biol; 2003 Mar; 327(3):699-709. PubMed ID: 12634062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the structure and dynamics of a near-native equilibrium intermediate in the unfolding pathway of an all beta-barrel protein.
    Srimathi T; Kumar TK; Chi YH; Chiu IM; Yu C
    J Biol Chem; 2002 Dec; 277(49):47507-16. PubMed ID: 12226076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure and stability of an acidic fibroblast growth factor from Notophthalmus viridescens.
    Arunkumar AI; Srisailam S; Kumar TK; Kathir KM; Chi YH; Wang HM; Chang GG; Chiu I; Yu C
    J Biol Chem; 2002 Nov; 277(48):46424-32. PubMed ID: 12205097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Partially folded intermediates as critical precursors of light chain amyloid fibrils and amorphous aggregates.
    Khurana R; Gillespie JR; Talapatra A; Minert LJ; Ionescu-Zanetti C; Millett I; Fink AL
    Biochemistry; 2001 Mar; 40(12):3525-35. PubMed ID: 11297418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The acid-mediated denaturation pathway of transthyretin yields a conformational intermediate that can self-assemble into amyloid.
    Lai Z; Colón W; Kelly JW
    Biochemistry; 1996 May; 35(20):6470-82. PubMed ID: 8639594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyloid fibril formation by an SH3 domain.
    Guijarro JI; Sunde M; Jones JA; Campbell ID; Dobson CM
    Proc Natl Acad Sci U S A; 1998 Apr; 95(8):4224-8. PubMed ID: 9539718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amyloid fibril formation of the mouse V(L) domain at acidic pH.
    Martsev SP; Dubnovitsky AP; Vlasov AP; Hoshino M; Hasegawa K; Naiki H; Goto Y
    Biochemistry; 2002 Mar; 41(10):3389-95. PubMed ID: 11876647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oligomerization of acidic fibroblast growth factor is not a prerequisite for its cell proliferation activity.
    Arunkumar AI; Kumar TK; Kathir KM; Srisailam S; Wang HM; Leena PS; Chi YH; Chen HC; Wu CH; Wu RT; Chang GG; Chiu IM; Yu C
    Protein Sci; 2002 May; 11(5):1050-61. PubMed ID: 11967362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Partial denaturation of transthyretin is sufficient for amyloid fibril formation in vitro.
    Colon W; Kelly JW
    Biochemistry; 1992 Sep; 31(36):8654-60. PubMed ID: 1390650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conformational transitions of islet amyloid polypeptide (IAPP) in amyloid formation in vitro.
    Kayed R; Bernhagen J; Greenfield N; Sweimeh K; Brunner H; Voelter W; Kapurniotu A
    J Mol Biol; 1999 Apr; 287(4):781-96. PubMed ID: 10191146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Congo red populates partially unfolded states of an amyloidogenic protein to enhance aggregation and amyloid fibril formation.
    Kim YS; Randolph TW; Manning MC; Stevens FJ; Carpenter JF
    J Biol Chem; 2003 Mar; 278(12):10842-50. PubMed ID: 12529361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the transthyretin acid denaturation pathways by analytical ultracentrifugation: implications for wild-type, V30M, and L55P amyloid fibril formation.
    Lashuel HA; Lai Z; Kelly JW
    Biochemistry; 1998 Dec; 37(51):17851-64. PubMed ID: 9922152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrasonication-induced amyloid fibril formation of beta2-microglobulin.
    Ohhashi Y; Kihara M; Naiki H; Goto Y
    J Biol Chem; 2005 Sep; 280(38):32843-8. PubMed ID: 16046408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A cylinder-shaped double ribbon structure formed by an amyloid hairpin peptide derived from the beta-sheet of murine PrP: an X-ray and molecular dynamics simulation study.
    Croixmarie V; Briki F; David G; Coïc YM; Ovtracht L; Doucet J; Jamin N; Sanson A
    J Struct Biol; 2005 Jun; 150(3):284-99. PubMed ID: 15890277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.